Skip to content

OS Therapies OSTX Royalty Reduction Percentage

Royalty Reduction Percentage at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
3%0.0pp
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
1%
Flanigan's Enterprises logo
Flanigan's EnterprisesBDL
1%0.0pp
Sutro Biopharma logo
Sutro BiopharmaSTRO
4%0.0pp
TMC the metals company Inc. logo
TMC the metals company Inc.TMC
2%
Zymeworks logo
ZymeworksZYME
2.5%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:RoyaltyReductionPercentage.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's royalty reduction percentage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's royalty reduction percentage?
OS Therapies (OSTX) reported royalty reduction percentage of 3% in Q1 2026.
How has OS Therapies's royalty reduction percentage changed year-over-year?
OS Therapies's royalty reduction percentage decreased by 0.0% year-over-year, from 3% to 3%.
What does royalty reduction percentage mean?
Represents the specific percentage by which royalty obligations are decreased under contractual agreements. This metric is used to track cost-saving adjustments in licensing or intellectual property arrangements.